Vitamin D, Insulin Resistance, and Type 2 Diabetes

Current Cardiovascular Risk Reports

Volumn 4, Issue 1, 2010, Pages 40-47

  Song, Yiqing ^a   Manson, JoAnn E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Insulin resistance; Insulin secretion; Type 2 diabetes; Vitamin D; Vitamin D receptor

Indexed keywords

EID: 79956111707     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-009-0071-2     Document Type: Article

References (42)

1. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: United States 2007. Atlanta, GA: US Department of Health and Human Services; 2007.
2. Stumvoll M, Goldstein BJ, van Haeften TW: Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365: 1333-1346.
3. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21: 1414-1431.
4. Wild S, Roglic G, Green A, et al.: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27: 1047-1053.
5. Kahn CR: Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994, 43: 1066-1084.
6. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37: 1595-1607.
7. Holick MF: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004, 79: 362-371.
8. •• Holick MF: Vitamin D deficiency. N Engl J Med 2007, 357: 266-281. This review focuses on the nature of vitamin D deficiency and summarized evidence linking vitamin deficiency to a wide variety of chronic diseases, including common cancers, autoimmune, cardiovascular, and infectious diseases. In addition, the author emphasizes the epidemic of vitamin D deficiency and the importance of adequate vitamin D by synthesis in the skin or from dietary and supplemental sources for overall health and well being throughout life.
9. Norman AW: From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008, 88: 491S-499S.
10. Forouhi NG, Luan J, Cooper A, et al.: Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008, 57: 2619-2625.
11. • Knekt P, Laaksonen M, Mattila C, et al.: Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008, 19: 666-671. This study combined data from two nested case-control studies from two Finnish cohorts to provide prospective evidence on the relation of serum vitamin D with type 2 diabetes incidence. The results support the hypothesis that high vitamin D status provides protection against type 2 diabetes.
12. Mattila C, Knekt P, Mannisto S, et al.: Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007, 30: 2569-2570.
13. Hollis BW, Kamerud JQ, Selvaag SR, et al.: Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 1993, 39: 529-533.
14. Hollis BW, Napoli JL: Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem 1985, 31: 1815-1819.
15. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al.: Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002, 76: 187-192.
16. • Ginde AA, Liu MC, Camargo CA Jr: Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009, 169: 626-632. This national population-based study evaluated US population trends in vitamin D insufficiency by age, sex, and ethnicity strata comparing serum 25[OH]D levels from NHANES-III, collected during 1988 through 1994, with NHANES data collected from 2001 through 2004 (NHANES 2001-2004). The results showed a marked decrease in serum 25(OH)D levels with racial/ethnic differences, indicating a growing epidemic of vitamin D insufficiency in the US general population.
17. Liel Y, Ulmer E, Shary J, et al.: Low circulating vitamin D in obesity. Calcif Tissue Int 1988, 43: 199-201.
18. Wortsman J, Matsuoka LY, Chen TC, et al.: Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000, 72: 690-693. (Published erratum appears in Am J Clin Nutr 2003, 77: 1342.).
19. Parikh SJ, Edelman M, Uwaifo GI, et al.: The relationship between obesity and serum 1, 25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004, 89: 1196-1199.
20. •• Pittas AG, Lau J, Hu FB, Dawson-Hughes B: The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92: 2017-2029. This systematic review and meta-analysis summarized observational studies and clinical trials through January 2007 for vitamin D and calcium and outcomes related to glucose homeostasis. The results showed a relatively consistent association between low vitamin D status, calcium or dairy intake, and prevalent type 2 diabetes or metabolic syndrome, although most observational studies were cross-sectional and intervention studies were short in duration, included few subjects, used a variety of formulations of vitamin D and calcium, or did post hoc analyses.
21. Norman AW, Frankel JB, Heldt AM, Grodsky GM: Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980, 209: 823-825.
22. Zeitz U, Weber K, Soegiarto DW, et al.: Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. Faseb J 2003, 17: 509-511.
23. Liu E, Meigs JB, Pittas AG, et al.: Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009, 139: 329-334.
24. Chiu KC, Chu A, Go VL, Saad MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79: 820-825.
25. Liu S, Song Y, Ford ES, et al.: Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U. S. women. Diabetes Care 2005, 28: 2926-2932.
26. Pittas AG, Dawson-Hughes B, Li T, et al.: Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29: 650-656.
27. Ogunkolade BW, Boucher BJ, Prahl JM, et al.: Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002, 51: 2294-2300.
28. Oh JY, Barrett-Connor E: Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002, 51: 356-359.
29. Ortlepp JR, Metrikat J, Albrecht M, et al.: The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 2003, 20: 451-454.
30. Ye WZ, Reis AF, Dubois-Laforgue D, et al.: Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol 2001, 145: 181-186.
31. Sone T, Marx SJ, Liberman UA, Pike JW: A unique point mutation in the human vitamin D receptor chromosomal gene confers hereditary resistance to 1, 25-dihydroxyvitamin D3. Mol Endocrinol 1990, 4: 623-631.
32. Fang Y, van Meurs JB, d'Alesio A, et al.: Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study. Am J Hum Genet 2005, 77: 807-823.
33. Malecki MT, Frey J, Moczulski D, et al.: Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp Clin Endocrinol Diabetes 2003, 111: 505-509.
34. Boucher BJ, Mannan N, Noonan K, et al.: Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 1995, 38: 1239-1245.
35. Gedik O, Akalin S: Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 1986, 29: 142-145.
36. Orwoll E, Riddle M, Prince M: Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1994, 59: 1083-1087.
37. Fliser D, Stefanski A, Franek E, et al.: No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 1997, 27: 629-633.
38. 3supplementation improves postprandial insulin sensitivity (oral glucose insulin sensitivity) in apparently healthy men likely to have insulin resistance (centrally obese but nondiabetic).
39. • Pittas AG, Harris SS, Stark PC, Dawson-Hughes B: The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007, 30: 980-986. This post-hoc analysis using the data from a double-blind, randomized, controlled trial showed that supplementation with calcium and vitamin D may attenuate increases in glycemia and insulin resistance in healthy, older adults with impaired fasting glucose.
40. Zittermann A, Frisch S, Berthold HK, et al.: Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009, 89: 1321-1327.
41. 3(400 IU daily) supplementation did not reduce the risk of developing diabetes over 7 years of follow-up among 33, 951 participants free of diabetes at baseline.
42. Dawson-Hughes B, Heaney RP, Holick MF, et al.: Estimates of optimal vitamin D status. Osteoporos Int 2005, 16: 713-716.